A patient with high normal blood pressure - Should we treat?

Blood Pressure

Volumn 14, Issue SUPPL. 2, 2005, Pages 50-52

  Czarnecka, Danuta ^a   Bilo, Grzegorz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Cardiovascular risk; High normal blood pressure; Hypertension; Non pharmacological treatment; Prehypertension

Indexed keywords

ENALAPRIL; NISOLDIPINE; PERINDOPRIL; PLACEBO; RAMIPRIL;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DISEASE CLASSIFICATION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIFESTYLE; MORTALITY; PHYSICAL ACTIVITY; POPULATION DISTRIBUTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; DRUG EFFECT; NOMENCLATURE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIFE STYLE; MALE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; HYPERTENSION; TERMINOLOGY;

EID: 31744445062     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08038020500424715     Document Type: Article

References (12)

1. (2003) 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens, 21, pp. 1011 - 1053.
2. Chobanian, A. V. and Bakris, G. L. and Black, H. R. and Cushman, W. C. and Green, L. A. and Izzo, J. L Jr. and (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA, 289, pp. 2560 - 2572.
3. Zdrojewski, T. and Szpakowski, P. and Bandosz, P. and Pajak, A. and Wiecek, A. and Krupa-Wojciechowska, B. and (2004) Arterial hypertension in Poland in 2002. J Hum Hypertens, 18, pp. 557 - 562.
4. Mancia, G. and Facchetti, R. and Bombelli, M. and Friz, H. P. and Grassi, G. and Giannattasio, C. and (2005) Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension, 45, pp. 1072 - 1077.
5. Vasan, R. S. and Larson, M. G. and Leip, E. P. and Kannel, W. B. and Levy, D. (2001) Assessment of frequency to progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study. Lancet, 358, pp. 1682 - 1686.
6. Vasan, R. S. and Larson, M. G. and Leip, E. P. and Evans, J. C. and O'Donnell, C. J. and Kannel, W. B. and (2001) Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med, 345, pp. 1291 - 1297.
7. Li, C. and Engstrom, G. and Hedblad, B. and Berglund, G. and Janzon, L. (2005) Blood pressure control and risk of stroke: A population-based prospective cohort study. Stroke, 36, pp. 725 - 730.
8. Mainous, A. G. and Everett, C. J. and Liszka, H. and King, D. E. and Egan, B. M. (2004) Prehypertension and mortality in a nationally representative cohort. Am J Cardiol, 94, pp. 1496 - 1500.
9. Selenta, C. and Hogan, B. E. and Linden, W. (2000) How often do office blood pressure measurements fail to identify true hypertension? An exploration of white-coat normotension. Arch Fam Med, 9, pp. 533 - 540.
10. The Heart Outcomes Prevention Evaluation Study Investigators. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med, 342, pp. 145 - 153.
11. PROGRESS Collaborative Study Group. (2001) Randomised trial of perindopril based blood pressure-lowering regimen among 6108 individuals with previous stroke or transient ischaemic attack. Lancet, 358, pp. 1033 - 1041.
12. Schrier, R. W. and Estacio, R. O. and Esler, A. and Mehler, P. (2002) Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and stroke. Kidney Int, 61, pp. 1086 - 1097.